Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma

被引：0
|
作者：
Alnimer, Yanal [1 ]
Yalniz, Fevzi [2 ]
Monohan, Gregory [2 ]
Munker, Reinhold [2 ]
Qasrawi, Ayman [3 ]
Iragavarapu, Chait [3 ]
Amr, Mahmoud [3 ]
机构：
[1] Univ Kentucky, Tappahannock, VA USA
[2] Univ Kentucky, Dept Hematol, Lexington, KY USA
[3] Univ Kentucky, Lexington, KY USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-211992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6320 / 6321
页数：2
相关论文
共 50 条
  • [41] Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
    Patel, Dilan A.
    Wan, Fei
    Trinkaus, Kathryn
    Guy, Daniel G.
    Edwin, Natasha
    Watkins, Marcus
    Bartlett, Nancy L.
    Cashen, Amanda
    Fehniger, Todd A.
    Ghobadi, Armin
    Shah, Neha-Mehta
    Kahl, Brad S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07) : 552 - 560
  • [42] Rituximab, gemcitabine and oxaliplatinum: An effective regimen in patients with refractory and relapsing mantle cell lymphoma
    Rodriguez, J.
    Gutierrez, A.
    Palacios, A.
    Navarrete, M.
    Blancas, I.
    Alarcon, J.
    Mut, P.
    Lopez, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 431 - 432
  • [43] Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen
    Reddy, Nishitha
    Greer, John P.
    Goodman, Stacey
    Kassim, Adetola
    Morgan, David S.
    Chinratanalab, Wichai
    Brandt, Stephen
    Englehardt, Brian
    Oluwole, Olalekan
    Jagasia, Madan H.
    Savani, Bipin N.
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (05) : 359 - 366
  • [44] Rituximab, gemcitabine and oxaliplatin:: An effective regimen in patients with refractory and relapsing mantle cell lymphoma
    Rodriguez, Jose
    Gutierrez, Antonio
    Palacios, Andres
    Navarrete, Mayda
    Blancas, Isabel
    Alarcon, Jesus
    Caballero, Maria D.
    de Mattos, Silvia Fernandez
    Gines, Jordi
    Martinez, Jordi
    Lopez, Andres
    LEUKEMIA & LYMPHOMA, 2007, 48 (11) : 2172 - 2178
  • [45] Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
    Yi, Jun Ho
    Kim, Seok Jin
    Lee, Jeong-ok
    Lee, Gyeong-won
    Kwak, Jae-yong
    Eom, Hyeon-seok
    Jo, Jae-cheol
    Choi, Yoon Seok
    Oh, Sung Yong
    Kim, Won Seog
    ANTICANCER RESEARCH, 2022, 42 (12) : 6083 - 6089
  • [46] Effects of Rituximab, Bortezomib, and Bendamustine on the Survival in Medicare Beneficiaries with Mantle Cell Lymphoma
    Fu, Shuangshuang
    Wang, Michael
    Zhao, Hui
    Li, Ruosha
    Lairson, David
    Giordano, Sharon
    Zhao, Bo
    Du, Xianglin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S273 - S274
  • [47] Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma
    Sarkozy, Clementine
    Callanan, Mary
    Thieblemont, Catherine
    Oberic, Lucie
    Burroni, Barbara
    Bouabdallah, Krimo
    Damaj, Gandhi
    Tessoulin, Benoit
    Ribrag, Vincent
    Houot, Roch
    Morschhauser, Franck
    Griolet, Samuel
    Joubert, Clementine
    Cacheux, Victoria
    Delwail, Vincent
    Safar, Violaine
    Gressin, Remy
    Cheminant, Morgane
    Delfau-Larue, Marie-Helene
    Hermine, Olivier
    Macintyre, Elizabeth
    Le Gouill, Steven
    BLOOD, 2024, 144 (03) : 262 - 271
  • [48] Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma - a Follow up Report of the Multicenter Study
    Vorobyev, Vladimir I.
    Kravchenko, Sergei K.
    Gemdzhian, Eduard G.
    Mangasarova, Jana K.
    Baryakh, Elena
    Kovrigina, Alla M.
    Obukhova, Tatiana N.
    Kaplanov, Kamil
    Dubrovin, Egor I.
    Vorobjev, Ivan A.
    Turina, Natalya G.
    Savchenko, Valeri G.
    BLOOD, 2014, 124 (21)
  • [49] Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
    Albertsson-Lindblad, Alexandra
    Kolstad, Arne
    Laurell, Anna
    Raty, Riikka
    Gronbaek, Kirsten
    Sundberg, Jan
    Pedersen, Lone Bredo
    Ralfkiaer, Elisabeth
    Karjalainen-Lindsberg, Marja-Liisa
    Sundstrom, Christer
    Ehinger, Mats
    Geisler, Christian
    Jerkeman, Mats
    BLOOD, 2016, 128 (14) : 1814 - 1820
  • [50] Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma
    Ito, Kaori
    Okamoto, Masataka
    Ando, Maiko
    Kakumae, Yukiko
    Okamoto, Akinao
    Inaguma, Yoko
    Tokuda, Masutaka
    Yanada, Masamitsu
    Yamada, Shigeki
    Emi, Nobuhiko
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 1123 - 1125
12345